263 related articles for article (PubMed ID: 32719257)
1. Quality of life of head and neck cancer patients before and after cancer-directed treatment - A longitudinal study.
Bashir A; Kumar D; Dewan D; Sharma R
J Cancer Res Ther; 2020; 16(3):500-507. PubMed ID: 32719257
[TBL] [Abstract][Full Text] [Related]
2. Exploring quality of life among head-and-neck cancer patients in Western India using European organization for research and treatment of cancer questionnaires.
Parkar S; Sharma A; Shah M
J Cancer Res Ther; 2022; 18(4):990-996. PubMed ID: 36149151
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study on the relationships between global health/quality of life and specific head and neck cancer quality of life domains in Puerto Rico.
Psoter WJ; Aguilar ML; Levy A; Baek LS; Morse DE
J Prosthodont; 2012 Aug; 21(6):460-71. PubMed ID: 22469330
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.
Bjordal K; Hammerlid E; Ahlner-Elmqvist M; de Graeff A; Boysen M; Evensen JF; Biörklund A; de Leeuw JR; Fayers PM; Jannert M; Westin T; Kaasa S
J Clin Oncol; 1999 Mar; 17(3):1008-19. PubMed ID: 10071296
[TBL] [Abstract][Full Text] [Related]
6. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
[TBL] [Abstract][Full Text] [Related]
7. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
[TBL] [Abstract][Full Text] [Related]
8. Two-year evolution of quality of life following radiotherapy and/or chemotherapy in patients with head and neck cancer.
Iwanaga K; Ishibashi Y; Maki K; Ura A; Kotake K; Haba K; Sakata T; Nakagawa T; Arima H
Asia Pac J Oncol Nurs; 2023 Nov; 10(11):100301. PubMed ID: 37885764
[TBL] [Abstract][Full Text] [Related]
9. Population-based reference values for the European Organization for Research and Treatment of Cancer Head and Neck module.
Hammerlid E; Adnan A; Silander E
Head Neck; 2017 Oct; 39(10):2036-2047. PubMed ID: 28708279
[TBL] [Abstract][Full Text] [Related]
10. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
11. Increased Pain Reporting by Head and Neck Cancer Patients at Radiation Oncology Consultation: A Quality-of-Life Analysis.
Havard M; Esslinger H; Mierzwa M; Kharofa J; Takiar V
Laryngoscope; 2021 Feb; 131(2):326-332. PubMed ID: 32609888
[TBL] [Abstract][Full Text] [Related]
12. The validity and reliability of the Turkish version of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer.
Senkal HA; Hayran M; Karakaya E; Yueh B; Weymuller EA; Hoşal AŞ
Am J Otolaryngol; 2012; 33(4):417-26. PubMed ID: 22137146
[TBL] [Abstract][Full Text] [Related]
13. Prospective, longitudinal quality-of-life study of patients with head and neck cancer: a feasibility study including the EORTC QLQ-C30.
Hammerlid E; Bjordal K; Ahlner-Elmqvist M; Jannert M; Kaasa S; Sullivan M; Westin T
Otolaryngol Head Neck Surg; 1997 Jun; 116(6 Pt 1):666-73. PubMed ID: 9215381
[TBL] [Abstract][Full Text] [Related]
14. Acute Stage Longitudinal Change of Quality of Life from Pre- to 3 Months after Surgical Treatment in Head and Neck Cancer Patients.
Tashimo Y; Ihara Y; Yuasa K; Nozue S; Saito Y; Katsuta H; Shimane T; Takahashi K
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3129-3136. PubMed ID: 31653164
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
16. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.
Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3495-3505. PubMed ID: 31529149
[TBL] [Abstract][Full Text] [Related]
17. Explorative study on quality of life in relation to salivary secretion rate in patients with head and neck cancer treated with radiotherapy.
Almståhl A; Alstad T; Fagerberg-Mohlin B; Carlén A; Finizia C
Head Neck; 2016 May; 38(5):782-91. PubMed ID: 25537660
[TBL] [Abstract][Full Text] [Related]
18. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Bottomley A; Tridello G; Coens C; Rolland F; Tesselaar ME; Leemans CR; Hupperets P; Licitra L; Vermorken JB; Van Den Weyngaert D; Truc G; Barillot I; Lefebvre JL
Cancer; 2014 Feb; 120(3):390-8. PubMed ID: 24452673
[TBL] [Abstract][Full Text] [Related]
19. Identifying cutoff scores for the EORTC QLQ-C30 and the head and neck cancer-specific module EORTC QLQ-H&N35 representing unmet supportive care needs in patients with head and neck cancer.
Jansen F; Snyder CF; Leemans CR; Verdonck-de Leeuw IM
Head Neck; 2016 Apr; 38 Suppl 1():E1493-500. PubMed ID: 27111696
[TBL] [Abstract][Full Text] [Related]
20. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI).
Trotti A; Johnson DJ; Gwede C; Casey L; Sauder B; Cantor A; Pearlman J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):257-61. PubMed ID: 9788402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
